Table 2:

Estimation based on non-mixture cure rate model

Variable		β	sd	Percentile			Exp(β)	95% HPD Interval
				25	50	75
Age at diagnosis	Under 40 yrs.	0.461	0.179	0.338	0.462	0.584	1.586*	0.117	0.808
	40 to 60 yrs.	0.283	0.149	0.182	0.283	0.386	1.328*	0.002	0.577
	Over 60 yrs.	REF
	No	REF
Type of surgery	BCS	−0.034	0.113	−0.112	−0.031	0.043	0.967	−0.245	0.190
	MRM	REF
Tumor size	T1	1.325	0.190	1.190	1.325	1.454	3.761*	0.959	1.688
	T2	0.523	0.137	0.429	0.523	0.616	1.687*	0.244	0.778
	T3+	REF
Lymph node status	N0	1.011	0.210	0.868	1.013	1.155	2.747*	0.623	1.435
	N1	0.081	0.156	−0.026	0.085	0.188	1.085	−0.212	0.388
	N2+	REF
Stage	I	0.618	0.265	0.434	0.611	0.793	1.854*	0.121	1.158
	II	0.044	0.132	−0.047	0.040	0.131	1.045	−0.211	0.304
	III+	REF
Histologic grade	Well	1.097	0.269	0.915	1.095	1.272	2.995*	0.599	1.639
	Moderately	0.203	0.113	0.128	0.204	0.279	1.225	−0.012	0.434
	Poorly	REF
Lymphovascular invasion	Positive(+)	−1.139	0.122	−1.221	−1.143	−1.056	0.320*	−1.373	−0.900
	Negative(−)	REF
Estrogen receptor	Positive(+)	0.440	0.163	0.330	0.442	0.551	1.553*	0.137	0.771
	Negative(−)	REF
Progesterone receptor	Positive(+)	0.475	0.158	0.374	0.473	0.582	1.608*	0.165	0.781
	Negative(−)	REF

^*) significant based on 95% HPD interval.